Using metabolomics to investigate the relationship between the metabolomic profile of the intestinal microbiota derivatives and mental disorders in inflammatory bowel diseases: a narrative review

Individuals with inflammatory bowel disease (IBD) are at a higher risk of developing mental disorders, such as anxiety and depression. The imbalance between the intestinal microbiota and its host, known as dysbiosis, is one of the factors, disrupting the balance of metabolite production and their si...

Full description

Saved in:
Bibliographic Details
Main Authors: Parvin Zarei, Peyman Adibi Sedeh, Ahmad Vaez, Ammar Hassanzadeh Keshteli
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Research in Pharmaceutical Sciences
Subjects:
Online Access:https://journals.lww.com/10.4103/RPS.RPS_273_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849704891252998144
author Parvin Zarei
Peyman Adibi Sedeh
Ahmad Vaez
Ammar Hassanzadeh Keshteli
author_facet Parvin Zarei
Peyman Adibi Sedeh
Ahmad Vaez
Ammar Hassanzadeh Keshteli
author_sort Parvin Zarei
collection DOAJ
description Individuals with inflammatory bowel disease (IBD) are at a higher risk of developing mental disorders, such as anxiety and depression. The imbalance between the intestinal microbiota and its host, known as dysbiosis, is one of the factors, disrupting the balance of metabolite production and their signaling pathways, leading to disease progression. A metabolomics approach can help identify the role of gut microbiota in mental disorders associated with IBD by evaluating metabolites and their signaling comprehensively. This narrative review focuses on metabolomics studies that have comprehensively elucidated the altered gut microbial metabolites and their signaling pathways underlying mental disorders in IBD patients. The information was compiled by searching PubMed, Web of Science, Scopus, and Google Scholar from 2005 to 2023. The findings indicated that intestinal microbial dysbiosis in IBD patients leads to mental disorders such as anxiety and depression through disturbances in the metabolism of carbohydrates, sphingolipids, bile acids, neurotransmitters, neuroprotective, inflammatory factors, and amino acids. Furthermore, the reduction in the production of neuroprotective factors and the increase in inflammation observed in these patients can also contribute to the worsening of psychological symptoms. Analyzing the metabolite profile of the patients and comparing it with that of healthy individuals using advanced technologies like metabolomics, aids in the early diagnosis and prevention of mental disorders. This approach allows for the more precise identification of the microbes responsible for metabolite production, enabling the development of tailored dietary and pharmaceutical interventions or targeted manipulation of microbiota.
format Article
id doaj-art-392716af89fa4248bd7aea3f1eee11cf
institution DOAJ
issn 1735-5362
1735-9414
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Research in Pharmaceutical Sciences
spelling doaj-art-392716af89fa4248bd7aea3f1eee11cf2025-08-20T03:16:36ZengWolters Kluwer Medknow PublicationsResearch in Pharmaceutical Sciences1735-53621735-94142025-01-0120112410.4103/RPS.RPS_273_23Using metabolomics to investigate the relationship between the metabolomic profile of the intestinal microbiota derivatives and mental disorders in inflammatory bowel diseases: a narrative reviewParvin ZareiPeyman Adibi SedehAhmad VaezAmmar Hassanzadeh KeshteliIndividuals with inflammatory bowel disease (IBD) are at a higher risk of developing mental disorders, such as anxiety and depression. The imbalance between the intestinal microbiota and its host, known as dysbiosis, is one of the factors, disrupting the balance of metabolite production and their signaling pathways, leading to disease progression. A metabolomics approach can help identify the role of gut microbiota in mental disorders associated with IBD by evaluating metabolites and their signaling comprehensively. This narrative review focuses on metabolomics studies that have comprehensively elucidated the altered gut microbial metabolites and their signaling pathways underlying mental disorders in IBD patients. The information was compiled by searching PubMed, Web of Science, Scopus, and Google Scholar from 2005 to 2023. The findings indicated that intestinal microbial dysbiosis in IBD patients leads to mental disorders such as anxiety and depression through disturbances in the metabolism of carbohydrates, sphingolipids, bile acids, neurotransmitters, neuroprotective, inflammatory factors, and amino acids. Furthermore, the reduction in the production of neuroprotective factors and the increase in inflammation observed in these patients can also contribute to the worsening of psychological symptoms. Analyzing the metabolite profile of the patients and comparing it with that of healthy individuals using advanced technologies like metabolomics, aids in the early diagnosis and prevention of mental disorders. This approach allows for the more precise identification of the microbes responsible for metabolite production, enabling the development of tailored dietary and pharmaceutical interventions or targeted manipulation of microbiota.https://journals.lww.com/10.4103/RPS.RPS_273_23anxietydepressiongastrointestinal microbiomeinflammatory bowel diseasesmetabolomics
spellingShingle Parvin Zarei
Peyman Adibi Sedeh
Ahmad Vaez
Ammar Hassanzadeh Keshteli
Using metabolomics to investigate the relationship between the metabolomic profile of the intestinal microbiota derivatives and mental disorders in inflammatory bowel diseases: a narrative review
Research in Pharmaceutical Sciences
anxiety
depression
gastrointestinal microbiome
inflammatory bowel diseases
metabolomics
title Using metabolomics to investigate the relationship between the metabolomic profile of the intestinal microbiota derivatives and mental disorders in inflammatory bowel diseases: a narrative review
title_full Using metabolomics to investigate the relationship between the metabolomic profile of the intestinal microbiota derivatives and mental disorders in inflammatory bowel diseases: a narrative review
title_fullStr Using metabolomics to investigate the relationship between the metabolomic profile of the intestinal microbiota derivatives and mental disorders in inflammatory bowel diseases: a narrative review
title_full_unstemmed Using metabolomics to investigate the relationship between the metabolomic profile of the intestinal microbiota derivatives and mental disorders in inflammatory bowel diseases: a narrative review
title_short Using metabolomics to investigate the relationship between the metabolomic profile of the intestinal microbiota derivatives and mental disorders in inflammatory bowel diseases: a narrative review
title_sort using metabolomics to investigate the relationship between the metabolomic profile of the intestinal microbiota derivatives and mental disorders in inflammatory bowel diseases a narrative review
topic anxiety
depression
gastrointestinal microbiome
inflammatory bowel diseases
metabolomics
url https://journals.lww.com/10.4103/RPS.RPS_273_23
work_keys_str_mv AT parvinzarei usingmetabolomicstoinvestigatetherelationshipbetweenthemetabolomicprofileoftheintestinalmicrobiotaderivativesandmentaldisordersininflammatoryboweldiseasesanarrativereview
AT peymanadibisedeh usingmetabolomicstoinvestigatetherelationshipbetweenthemetabolomicprofileoftheintestinalmicrobiotaderivativesandmentaldisordersininflammatoryboweldiseasesanarrativereview
AT ahmadvaez usingmetabolomicstoinvestigatetherelationshipbetweenthemetabolomicprofileoftheintestinalmicrobiotaderivativesandmentaldisordersininflammatoryboweldiseasesanarrativereview
AT ammarhassanzadehkeshteli usingmetabolomicstoinvestigatetherelationshipbetweenthemetabolomicprofileoftheintestinalmicrobiotaderivativesandmentaldisordersininflammatoryboweldiseasesanarrativereview